Singer Marybeth
Breast Cancer Program, Massachusetts General Hospital, Boston, Massachusetts, USA.
Oncology (Williston Park). 2007 Jul;21(8 Suppl):26-37; discussion 37-9.
Diabetes mellitus is a frequent comorbidity of cancer patients. The growing epidemic of diabetes is anticipated to have tremendous impact on health care. Diabetes may negatively impact both cancer risk and outcomes of treatment. Oncology nurses are ideally positioned to identify patients at risk for complications that arise from cancer treatment in the setting of pre-existing diabetes. Additionally, oncology nurses may be the first to identify underlying hyperglycemia/hidden diabetes in a patient undergoing cancer treatment. Strategies for assessment and treatment will be discussed, along with specific strategies for managing hyperglycemia, potential renal toxicity, and peripheral neuropathy. Guidelines for aggressive treatment of hyperglycemia to minimize risks of complications will be reviewed. The role of interdisciplinary care, utilizing current evidence, is crucial to supporting patients and their families as they manage the challenges of facing two life-limiting diseases. Whole-person assessment and individualized treatment plans are key to maximizing quality of life for patients with cancer and diabetes.
糖尿病是癌症患者常见的合并症。预计糖尿病的日益流行将对医疗保健产生巨大影响。糖尿病可能对癌症风险和治疗结果产生负面影响。肿瘤护士处于理想位置，能够识别在已有糖尿病背景下因癌症治疗而出现并发症风险的患者。此外，肿瘤护士可能是癌症治疗患者中最先识别潜在高血糖/隐匿性糖尿病的人。将讨论评估和治疗策略，以及管理高血糖、潜在肾毒性和周围神经病变的具体策略。将回顾积极治疗高血糖以尽量减少并发症风险的指南。利用现有证据的多学科护理对于支持患者及其家人应对面临两种危及生命疾病的挑战至关重要。全人评估和个性化治疗计划是提高癌症和糖尿病患者生活质量的关键。
